Knowledge (XXG)

Glomangiosarcoma

Source πŸ“

1101: 1086: 218:
has been previously described, the standard of care for malignant glomus tumors still involves wide local excision with negative surgical margins. It is not currently advised to use adjuvant
1116: 352:
Watanabe K, Sugino T, Saito A, Kusakabe T, Suzuki T (December 1998). "Glomangiosarcoma of the hip: report of a highly aggressive tumour with widespread distant metastases".
256:
PΓ©rez de la Fuente T, Vega C, Gutierrez Palacios A, Sanchez Lorenzo J, Gonzalez Sarasua J (2005). "Glomangiosarcoma of the hypothenar eminence: a case report".
110:
Typically, a definitive diagnosis cannot be made based solely on radiologic findings and clinical symptoms. To get a conclusive diagnosis of glomangiosarcoma,
1173: 763: 404:
Kayal JD, Hampton RW, Sheehan DJ, Washington CV (September 2001). "Malignant glomus tumor: a case report and review of the literature".
494: 292: 439:
Hiruta N, Kameda N, Tokudome T, et al. (September 1997). "Malignant glomus tumor: a case report and review of the literature".
530:
Alhroub, Omar A; Mahameed, Shimaa A; Abdelhafez, Mohammad O; Alhroub, Asil; Hour, Hani; Hasasna, Nabil; Kamal, Nazmi (2022-01-01).
913:
Oh, Stephen D.; Stephenson, Daniel; Schnall, Stephen; Fassola, Isabella; Dinh, Paul (2009). "Malignant Glomus Tumor of the Hand".
646:
Folpe, Andrew L.; Fanburg–Smith, Julie C.; Miettinen, Markku; Weiss, Sharon W. (2001). "Atypical and Malignant Glomus Tumors".
354: 1178: 479:"Locally infiltrative glomus tumors and glomangiosarcomas. A clinical, ultrastructural, and immunohistochemical study" 130: 801:"Histochemical investigation into the molecular mechanisms of malignant transformation in a benign glomus tumour" 215: 190:
These lesions in soft tissue and skin need to be distinguished from other cutaneous round cell malignancies such
587:
Wang, Yingjie; Xiang, Yongbo; Bian, Yanyan; Feng, Bin; Liu, Yong; Zhou, Xi; Zhou, Lizhi; Weng, Xisheng (2020).
960:
Rkiba, Zakaria; Rafai, Mohamed; Rajaallah, Abdessamad; Elkassimi, Charafeddine; Garch, Abdelhak (2021).
203: 141: 111: 379: 320: 191: 95: 1095: 1052: 1034: 999: 981: 938: 930: 895: 877: 838: 820: 775: 767: 728: 710: 671: 663: 628: 610: 569: 551: 506: 498: 456: 421: 371: 312: 273: 83: 38: 1042: 1024: 989: 973: 922: 885: 869: 828: 812: 759: 718: 702: 655: 618: 600: 559: 543: 490: 448: 413: 363: 304: 265: 328: 1047: 1012: 994: 961: 890: 857: 723: 690: 623: 588: 564: 531: 308: 195: 833: 800: 748:"Glomangiosarcoma in a glomus tumor. An immunohistochemical and ultrastructural study" 1167: 659: 452: 417: 367: 153: 383: 324: 1013:"Malignant Glomus Tumor (Glomangiosarcoma) of Intestinal Ileum: A Rare Case Report" 236: 231: 219: 184: 122: 99: 67: 115: 926: 706: 977: 175:. Studies conducted in the past have also revealed changes in the expression of 63: 59: 43: 764:
10.1002/1097-0142(19880401)61:7<1467::aid-cncr2820610733>3.0.co;2-3
269: 1110: 495:
10.1002/1097-0142(19900115)65:2<310::aid-cncr2820650221>3.0.co;2-q
125:
in that they include sheets of uniform, round to oval cells with eosinophilic
1038: 985: 934: 881: 824: 771: 714: 667: 614: 555: 502: 1124: 873: 126: 1056: 1003: 942: 899: 842: 747: 732: 675: 632: 573: 547: 478: 425: 316: 277: 1029: 816: 779: 510: 460: 375: 293:"Glomangiosarcoma of the hand: a case report and review of the literature" 605: 589:"Glomus tumors associated with the bone and joints: a review of 91 cases" 532:"A case of malignant glomus tumor (glomangiosarcoma) of the nasal cavity" 199: 172: 149: 71: 1078: 1011:
Abu-Zaid, Ahmed; Azzam, Ayman; Amin, Tarek; Mohammed, Shamayel (2013).
145: 137: 1105: 1090: 168: 1151: 856:
Binesh, F.; Akhavan, A.; Zahir, S. T.; Bovanlu, T. R. (2013-01-03).
176: 164: 160: 156: 55: 1129: 477:
EW, Gould; JC, Manivel; J, Albores-Saavedra; H, Monforte (1990).
689:
Maselli, Amy M.; Jambhekar, Amani V.; Hunter, John G. (2017).
180: 82:
Glomangiosarcoma usually manifest as painful blue-red dermal
66:, but metastases are possible. It is also known as malignant 921:(3). Ovid Technologies (Wolters Kluwer Health): 264–269. 163:. On the other hand, benign tumors stain more highly for 915:
Applied Immunohistochemistry & Molecular Morphology
701:(1). Ovid Technologies (Wolters Kluwer Health): e1219. 799:
Hegyi, L.; Cormack, G. C.; Grant, J. W. (1998-11-01).
654:(1). Ovid Technologies (Wolters Kluwer Health): 1–12. 472: 470: 695:
Plastic and Reconstructive Surgery β€” Global Open
121:
Histologically, glomangiosarcomas differ from benign
1068: 1139: 1072: 691:"Glomangiosarcoma Arising from a Prior Biopsy Site" 37: 29: 24: 962:"Malignant glomus tumor of the foot. Case report" 291:Park JH, Oh SH, Yang MH, Kim NI (November 2003). 171:, and malignant tumors stain more intensely for 966:International Journal of Surgery Case Reports 858:"Clinically malignant atypical glomus tumour" 8: 399: 397: 395: 393: 746:M, Aiba; A, Hirayama; S, Kuramochi (1988). 136:Glomangiosarcomas display many of the same 1069: 648:The American Journal of Surgical Pathology 441:The American Journal of Surgical Pathology 21: 1046: 1028: 993: 889: 832: 722: 622: 604: 563: 347: 345: 248: 129:, many vascular spaces, and cellular 7: 599:(21). AME Publishing Company: 1460. 133:linked to frequent mitotic figures. 16:Cancer originating in glomus bodies 309:10.1111/j.1346-8138.2003.tb00486.x 14: 86:that range from 0.5-2cm in size. 660:10.1097/00000478-200101000-00001 593:Annals of Translational Medicine 536:Journal of Surgical Case Reports 453:10.1097/00000478-199709000-00015 418:10.1097/00042728-200109000-00011 368:10.1046/j.1365-2133.1998.02574.x 140:as their benign counterparts on 1174:Dermal and subcutaneous growths 868:(jan03 1). BMJ: bcr2012007618. 355:British Journal of Dermatology 222:for primary glomangiosarcoma. 116:hematoxylin and eosin staining 1: 805:Journal of Clinical Pathology 98:or from a preexisting benign 927:10.1097/pai.0b013e31818a9d5d 707:10.1097/gox.0000000000001219 112:immunohistochemical staining 94:Glomangiosarcomas can arise 978:10.1016/j.ijscr.2021.01.050 1195: 297:The Journal of Dermatology 270:10.1016/j.main.2005.06.006 1017:Case Reports in Pathology 216:Mohs micrographic surgery 1023:. Hindawi Limited: 1–5. 972:. Elsevier BV: 413–416. 183:in comparison to benign 70:. Positive staining for 874:10.1136/bcr-2012-007618 159:, and muscle-specific 33:Malignant glomus tumor 817:10.1136/jcp.51.11.872 204:Merkel cell carcinoma 811:(11). BMJ: 872–874. 606:10.21037/atm-20-6998 548:10.1093/jscr/rjab641 406:Dermatologic Surgery 258:Chirurgie de la Main 1030:10.1155/2013/305321 142:immunohistochemical 74:has been reported. 1179:Types of neoplasia 1140:External resources 192:hemangiopericytoma 78:Signs and symptoms 1161: 1160: 49: 48: 19:Medical condition 1186: 1070: 1060: 1050: 1032: 1007: 997: 947: 946: 910: 904: 903: 893: 853: 847: 846: 836: 796: 790: 789: 787: 786: 758:(7): 1467–1471. 743: 737: 736: 726: 686: 680: 679: 643: 637: 636: 626: 608: 584: 578: 577: 567: 527: 521: 520: 518: 517: 474: 465: 464: 436: 430: 429: 401: 388: 387: 349: 340: 339: 337: 336: 327:. Archived from 288: 282: 281: 264:(3–4): 199–202. 253: 144:labeling; these 52:Glomangiosarcoma 25:Glomangiosarcoma 22: 1194: 1193: 1189: 1188: 1187: 1185: 1184: 1183: 1164: 1163: 1162: 1157: 1156: 1135: 1134: 1081: 1067: 1010: 959: 956: 954:Further reading 951: 950: 912: 911: 907: 855: 854: 850: 798: 797: 793: 784: 782: 745: 744: 740: 688: 687: 683: 645: 644: 640: 586: 585: 581: 529: 528: 524: 515: 513: 476: 475: 468: 447:(9): 1096–103. 438: 437: 433: 403: 402: 391: 362:(6): 1097–101. 351: 350: 343: 334: 332: 290: 289: 285: 255: 254: 250: 245: 228: 212: 114:in addition to 108: 92: 80: 54:is a low grade 20: 17: 12: 11: 5: 1192: 1190: 1182: 1181: 1176: 1166: 1165: 1159: 1158: 1155: 1154: 1144: 1143: 1141: 1137: 1136: 1133: 1132: 1121: 1113: 1098: 1082: 1077: 1076: 1074: 1073:Classification 1066: 1065:External links 1063: 1062: 1061: 1008: 955: 952: 949: 948: 905: 848: 791: 738: 681: 638: 579: 542:(1): rjab641. 522: 489:(2): 310–318. 466: 431: 389: 341: 303:(11): 827–33. 283: 247: 246: 244: 241: 240: 239: 234: 227: 224: 211: 208: 196:leiomyosarcoma 107: 104: 91: 88: 79: 76: 62:. They rarely 47: 46: 41: 35: 34: 31: 27: 26: 18: 15: 13: 10: 9: 6: 4: 3: 2: 1191: 1180: 1177: 1175: 1172: 1171: 1169: 1153: 1149: 1146: 1145: 1142: 1138: 1131: 1127: 1126: 1122: 1119: 1118: 1114: 1112: 1108: 1107: 1103: 1099: 1097: 1093: 1092: 1088: 1084: 1083: 1080: 1075: 1071: 1064: 1058: 1054: 1049: 1044: 1040: 1036: 1031: 1026: 1022: 1018: 1014: 1009: 1005: 1001: 996: 991: 987: 983: 979: 975: 971: 967: 963: 958: 957: 953: 944: 940: 936: 932: 928: 924: 920: 916: 909: 906: 901: 897: 892: 887: 883: 879: 875: 871: 867: 863: 859: 852: 849: 844: 840: 835: 830: 826: 822: 818: 814: 810: 806: 802: 795: 792: 781: 777: 773: 769: 765: 761: 757: 753: 749: 742: 739: 734: 730: 725: 720: 716: 712: 708: 704: 700: 696: 692: 685: 682: 677: 673: 669: 665: 661: 657: 653: 649: 642: 639: 634: 630: 625: 620: 616: 612: 607: 602: 598: 594: 590: 583: 580: 575: 571: 566: 561: 557: 553: 549: 545: 541: 537: 533: 526: 523: 512: 508: 504: 500: 496: 492: 488: 484: 480: 473: 471: 467: 462: 458: 454: 450: 446: 442: 435: 432: 427: 423: 419: 415: 412:(9): 837–40. 411: 407: 400: 398: 396: 394: 390: 385: 381: 377: 373: 369: 365: 361: 357: 356: 348: 346: 342: 331:on 2011-07-22 330: 326: 322: 318: 314: 310: 306: 302: 298: 294: 287: 284: 279: 275: 271: 267: 263: 259: 252: 249: 242: 238: 235: 233: 230: 229: 225: 223: 221: 217: 209: 207: 205: 201: 197: 193: 188: 186: 185:glomus tumors 182: 178: 174: 170: 166: 162: 158: 155: 154:smooth muscle 151: 147: 143: 139: 134: 132: 128: 124: 123:glomus tumors 119: 117: 113: 105: 103: 101: 100:glomus tumour 97: 89: 87: 85: 77: 75: 73: 69: 65: 61: 57: 53: 45: 42: 40: 36: 32: 28: 23: 1147: 1123: 1115: 1100: 1085: 1020: 1016: 969: 965: 918: 914: 908: 865: 862:Case Reports 861: 851: 808: 804: 794: 783:. Retrieved 755: 751: 741: 698: 694: 684: 651: 647: 641: 596: 592: 582: 539: 535: 525: 514:. Retrieved 486: 482: 444: 440: 434: 409: 405: 359: 353: 333:. Retrieved 329:the original 300: 296: 286: 261: 257: 251: 237:Glomus tumor 232:Angiosarcoma 220:chemotherapy 213: 189: 135: 131:pleomorphism 120: 109: 93: 81: 68:glomus tumor 51: 50: 118:is needed. 64:metastasize 60:soft tissue 44:Dermatology 30:Other names 1168:Categories 785:2024-04-27 516:2024-04-27 335:2008-10-17 243:References 1125:SNOMED CT 1039:2090-6781 986:2210-2612 935:1541-2016 882:1757-790X 825:0021-9746 772:0008-543X 715:2169-7574 668:0147-5185 615:2305-5839 556:2042-8812 503:0008-543X 214:Although 210:Treatment 127:cytoplasm 106:Diagnosis 39:Specialty 1152:Q5571213 1130:13875003 1120:: 8710/3 1057:23691399 1004:33524797 943:18997618 900:23291816 843:10193335 733:28203514 676:11145243 633:33313205 574:35096369 426:11553174 384:34576130 325:21334564 317:14684942 278:16121631 226:See also 200:melanoma 173:vimentin 150:vimentin 148:include 146:antigens 138:antigens 72:vimentin 1148:Scholia 1048:3638502 995:7851418 891:3603905 780:2449949 724:5293312 624:7723542 565:8791658 511:2153045 461:9298887 376:9990381 96:de novo 84:nodules 58:of the 1096:XH05Y1 1055:  1045:  1037:  1002:  992:  984:  941:  933:  898:  888:  880:  841:  834:500988 831:  823:  778:  770:  752:Cancer 731:  721:  713:  674:  666:  631:  621:  613:  572:  562:  554:  509:  501:  483:Cancer 459:  424:  382:  374:  323:  315:  276:  202:, and 169:myosin 90:Causes 1117:ICD-O 1111:D18.0 380:S2CID 321:S2CID 177:Bcl-2 165:actin 161:actin 157:actin 56:tumor 1053:PMID 1035:ISSN 1021:2013 1000:PMID 982:ISSN 939:PMID 931:ISSN 896:PMID 878:ISSN 866:2013 839:PMID 821:ISSN 776:PMID 768:ISSN 729:PMID 711:ISSN 672:PMID 664:ISSN 629:PMID 611:ISSN 570:PMID 552:ISSN 540:2022 507:PMID 499:ISSN 457:PMID 422:PMID 372:PMID 313:PMID 274:PMID 179:and 167:and 1102:ICD 1087:ICD 1043:PMC 1025:doi 990:PMC 974:doi 923:doi 886:PMC 870:doi 829:PMC 813:doi 760:doi 719:PMC 703:doi 656:doi 619:PMC 601:doi 560:PMC 544:doi 491:doi 449:doi 414:doi 364:doi 360:139 305:doi 266:doi 181:p53 1170:: 1150:: 1128:: 1109:: 1106:10 1094:: 1091:11 1051:. 1041:. 1033:. 1019:. 1015:. 998:. 988:. 980:. 970:79 968:. 964:. 937:. 929:. 919:17 917:. 894:. 884:. 876:. 864:. 860:. 837:. 827:. 819:. 809:51 807:. 803:. 774:. 766:. 756:61 754:. 750:. 727:. 717:. 709:. 697:. 693:. 670:. 662:. 652:25 650:. 627:. 617:. 609:. 595:. 591:. 568:. 558:. 550:. 538:. 534:. 505:. 497:. 487:65 485:. 481:. 469:^ 455:. 445:21 443:. 420:. 410:27 408:. 392:^ 378:. 370:. 358:. 344:^ 319:. 311:. 301:30 299:. 295:. 272:. 262:24 260:. 206:. 198:, 194:, 187:. 152:, 102:. 1104:- 1089:- 1079:D 1059:. 1027:: 1006:. 976:: 945:. 925:: 902:. 872:: 845:. 815:: 788:. 762:: 735:. 705:: 699:5 678:. 658:: 635:. 603:: 597:8 576:. 546:: 519:. 493:: 463:. 451:: 428:. 416:: 386:. 366:: 338:. 307:: 280:. 268::

Index

Specialty
Dermatology
tumor
soft tissue
metastasize
glomus tumor
vimentin
nodules
de novo
glomus tumour
immunohistochemical staining
hematoxylin and eosin staining
glomus tumors
cytoplasm
pleomorphism
antigens
immunohistochemical
antigens
vimentin
smooth muscle
actin
actin
actin
myosin
vimentin
Bcl-2
p53
glomus tumors
hemangiopericytoma
leiomyosarcoma

Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.

↑